Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)
This study has been completed.
Sponsor:
The University of Hong Kong
Collaborator:
Novartis Pharmaceuticals
Information provided by:
The University of Hong Kong
ClinicalTrials.gov Identifier:
NCT00804622
First received: December 8, 2008
Last updated: July 10, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | March 2010 |
| Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |